What this is
- This systematic review examines the impact of biological sex on fitness adaptations to high-intensity interval training (HIIT).
- The analysis includes data from 28 trials with a total of 965 participants, comparing outcomes between men and women.
- Key outcomes include maximal oxygen uptake and peak power output, with a focus on identifying sex-specific differences.
Essence
- Men and women show similar improvements in fitness and performance outcomes following HIIT, with no significant sex differences overall. However, well-trained women exhibit larger increases in peak power output compared to well-trained men.
Key takeaways
- Both men and women experience comparable increases in maximal oxygen uptake (O) after HIIT, suggesting that biological sex does not significantly influence fitness adaptations to this training method.
- Well-trained women display a greater improvement in peak power output compared to well-trained men, indicating potential differences in adaptation mechanisms despite overall similar outcomes.
- Intervention length significantly affects outcomes, with shorter training durations (≤4 weeks) yielding smaller effect sizes for both sexes.
Caveats
- The majority of included studies had small sample sizes, which may limit the generalizability of the findings and potentially overestimate effect sizes.
- Variability in training protocols and intervention lengths across studies complicates the assessment of how these factors influence outcomes.
- Future research should explore the influence of hormonal status on fitness adaptations, as this review did not address this important variable.
AI simplified
Introduction
High-intensity interval training (HIIT) involves repeated bouts of exercise performed in the vigorous intensity domain interspersed with periods of complete rest or low-intensity exercise. High-intensity intervals can last anywhere from 5 s to 8 min and are generally performed above the second ventilatory threshold which elicits a heart rate response between 80 to 100% of heart rate maximum [1]. Variables such as the interval duration, intensity, and the number of work and recovery bouts can be manipulated to develop a myriad of different HIIT protocols. When the work rate increases towards the upper bound of the typical intensity range for HIIT, a specific form of HIIT referred to as ‘sprint interval training’ (SIT) occurs. This involves very brief work bouts, usually around 8–30 s, that are repeated and performed at supra-maximal intensity (greater than that associated with 100% of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max) or ‘all-out’ efforts [2]. These relatively short intervals are also interspersed with either long or short recovery periods [3].
Previous studies have shown that HIIT can elicit equal or greater improvements in maximal oxygen uptake (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max) compared with continuous training [4–7], particularly with the use of higher intensities and longer work intervals [8, 9]. Currently, HIIT is increasingly prescribed as a potential therapeutic intervention to address a variety of chronic illnesses including cardiovascular disease, cancer, and metabolic syndrome, due to the robust evidence showing significantly enhanced cardiorespiratory fitness [6, 10–13]. The approach appears to be a viable strategy for fostering mental, psychological, and cognitive health and may reduce the severity of anxiety and depression [14–19]. Lastly, HIIT can be undertaken without the need for expensive gym equipment or access to commercial exercise training facilities. Overall, HIIT appears to be a feasible alternative to traditional endurance training for improving cardiorespiratory fitness, and may facilitate these changes with a surprisingly low training volume [20, 21].
Anatomical and physiological differences between men and women are believed to underlie differences in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and endurance performance [22]; however, differences in the adaptation to chronic training are less well known. Studies in which biological sex was treated as an independent variable have been considered crucial towards improving the understanding of overall human health, and also for enabling more personalized, sex-specific training regimens [23]. Compared with men, the absolute aerobic capacity of trained women is 10–25% lower, however, when maximal oxygen uptake (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max) is adjusted relative to body weight, the difference can be reduced to around 5–10% [24–26]. After normalization of body weight, the remaining difference could be due to lower blood hemoglobin concentration, cardiac dimensions, and total blood volume [24, 27–29]. For example, women's hearts and major blood vessels are typically smaller than those of men of the same body weight, ethnicity, and chronological age [22, 30–33]. Similarly, various studies have identified respiratory system limitations in women. Compared with men, height- and weight-matched women appear to have smaller lung sizes [34–36]. Furthermore, the diameter of the conducting airways is lower and the number of alveoli is less than in men, both of which negatively affect airflow and efficiency of gas exchange during heavy exercise [36–39]. Although some research indicates that performance could be impacted by sex differences in lung volume, but not airway anatomy and mechanics [22, 40, 41], such differences likely still contribute to physiological limitations to oxygen transport and thus would tend to exert a negative impact on exercise performance in women compared with age-, height- and/or weight-matched men.
Another physiological sex difference that has the potential to influence exercise response is that the less fatigable type I muscle fibers tend to be more abundant in women [42]. As such, there is evidence that for the same period of high-intensity exercise, women tend to experience less peripheral muscle fatigue-related contractile dysfunction than men, which translates to greater fatigue resistance and faster recovery [43]. Due to the differences in muscle fiber type percentages, women oxidize more fat and less protein and carbohydrate at matched relative intensity compared with men [44], whereas men possess higher glycolytic capacity [45, 46], which would therefore tend to alter intracellular homeostasis to a greater extent in men versus women at an equivalent relative intensity. Moreover, in response to HIIT or SIT, some studies have reported that females present with lower blood lactate levels [47]. Other findings have demonstrated that anaerobic capacity, estimated by energetic equivalents of the phosphagen and glycolytic pathways, may be lower in women when compared with men after a supramaximal effort [48]. Collectively, these studies suggest that women are less prone to peripheral muscle fatigue and have a greater tendency towards more aerobic metabolism than men.
To date, many reviews investigating the role of sex differences on acute exercise responses and chronic adaptation have been narrative in nature [2, 49]. One review concluded that attenuated blood lactate accumulation, lower protein synthesis, and mitochondrial biogenesis occur in women relative to men following SIT [2]. One systematic review, which also included a meta-regression [50], examined the effects of low-volume HIIT on cardiorespiratory fitness in adults and found moderate improvements in the \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max of active and sedentary participants, without presenting a conclusion regarding a sex-specific response to HIIT. A more recent meta-analysis concluded that HIIT is an efficient method of decreasing total abdominal and visceral fat mass without differences between men and women, but it did not investigate cardiorespiratory fitness as an outcome [51]. A meta-analysis by Diaz‑Canestro and Montero [52] found significantly larger increases in both absolute and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max after moderate-intensity endurance training in men compared with women; however, this review did not investigate the effects of HIIT as an intervention. Overall, the findings of these reviews indicate the potential for sex to impact health outcomes and cardiorespiratory fitness adaptations to exercise training, yet to date, no definitive conclusions can be drawn regarding how sex differences influence the adaptation to HIIT. Therefore, the objective of this systematic review with meta-analyses was to examine the influence of biological sex on the relative magnitude of adaptations in cardiorespiratory fitness and performance, following either HIIT or SIT interventions.
Methods
Development of the Research Question
To address the objective of the review, the research question was formulated using the Population, Intervention, Comparison, Outcome (PICO) framework as follows:
Is the relative magnitude of adaptation of maximal cardiorespiratory fitness and measures of performance (outcome) in response to HIIT or SIT (intervention) in healthy adults (population) different between men and women (comparison)?
Literature Search and Screening
This systematic review has been registered on the PROSPERO International Prospective Register of Systematic Reviews (registration number: CRD42021272615). Additionally, this review has been conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines [53].
A search of three major electronic databases (MEDLINE, Sports Medicine & Education Index in ProQuest, and SPORTDiscus) was undertaken through to 8 September 2022. The keywords used during the search were ‘high intensity’, ‘high-intensity’, ‘HIIT’, ‘HIT’, ‘intervals’, ‘intermittent’, ‘sprint’, ‘HIIE’, ‘vigorous’, ‘maximal’, ‘exercise’, ‘workout’, ‘intervention’, ‘physical activity, ‘activity’, ‘training’, ‘gender’, ‘sex’, ‘male’, ‘males’ ‘man’, or ‘men’ and ‘female’, ‘females’ ‘woman’, or ‘women’. Subject (MeSH) headings were used for ‘exercise’, ‘exercise training’, ‘exercise adaptation’, and ‘physical activity’ in MEDLINE and SPORTDiscus. The search strategy was recreated in the Sports Medicine & Education Index in ProQuest without the option of subject headings. The ProQuest search was set to search ‘everything except full text’, including title, abstract, and keywords. The full search strategy as it was undertaken in MEDLINE is outlined in Supplementary Online Resource 2 (see electronic supplementary material [ESM]). In addition, the reference lists of previous reviews relevant to HIIT were manually screened to identify any relevant references that were not included in the electronic search. All references captured in the search and identified from reference lists were exported into Zotero reference management software (version 5.0.96.2, USA), and subsequently imported into Covidence online review management program (Australia) for the study selection phase of the review.
Title, abstract screening, and full-text screening were conducted through the Covidence website by two independent reviewers (IY and ML). Any conflicts during the screening process were resolved via consultation between the two reviewers to confirm the reasons underlying inclusion or exclusion. A third reviewer was available for any conflicts that could not be resolved between the first two reviewers.
For inclusion in the review, studies were required to have implemented a HIIT or SIT protocol intervention in a cohort of adults including male and female participants; to have measured cardiorespiratory fitness or performance outcomes; to have presented separate outcomes for men and women, or individual data including sex, and/or presented results of a sex × HIIT analysis for the outcomes of interest. This approach to study inclusion was taken in order to control for confounding from different HIIT/SIT protocols across studies, and to ensure that exercise dose is normalized between male and female sub-groups. Peer-reviewed publications or unpublished theses that were written in English were included in the review. Participant groups were excluded from the review if clear pathology was present (i.e., if diagnosed diseases or disorders were a focus of the intervention) or if the intervention included major confounding factors (i.e., dietary supplementation or manipulation, pharmaceutical or herbal intervention, bed rest, or if HIIT/SIT was not the primary cardiorespiratory exercise intervention). Studies and participant groups with risk factors for disease were included if diagnosed disease states were not present. Research designs including reviews, previous meta-analyses, conference abstracts, case studies, and non-scientific articles were excluded from the review. Outcome measures included any measures relating to cardiorespiratory fitness, maximal or sub-maximal exercise performance including power, anaerobic threshold, or speed-related measures (i.e., time trials and sprints). Musculoskeletal performance outcomes such as field tests of muscular power, strength, or endurance were outside of the scope of the current review. No limitations were placed on the type of measure used for fitness or performance outcomes (i.e., measured vs estimated \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max, or lab-based vs field tests of performance) or whether or not the study achieved a positive effect overall.
Assessing the Risk of Bias Within Studies
The risk of bias for each of the individual included trials was evaluated independently by two authors (IY and ML) using the Newcastle–Ottawa Scale (NOS) for quality assessment of case–control studies [54]. To address the unique research question of the current review, the research team needed to focus on an observational element (biological sex differences in outcomes) within interventional studies, therefore a tool for assessing the risk of bias in observational studies was deemed to be more appropriate than a tool to assess the risk of bias within experimental studies. This approach has been previously used for another meta-analysis with a similar research question [52]. Additionally, to address the risk of bias specific to the research question, the comparison of men and women was applied to the NOS in place of cases versus controls.
Due to the risk of low inter-rater reliability associated with the subjective interpretation of the NOS and the previously highlighted need for more detailed guidance around the application of the scale [54–56], additional directions were developed by the research team to apply the NOS to the specific objectives of the current review (see Supplementary Online Resource 3 in the ESM). Studies were scored on a scale of nine in accordance with the NOS scoring system. Any conflicts in the quality rating scores of individual items within each study were resolved through discussion between the researchers. Inter-rater reliability for individual items of the NOS was calculated as the number of trials with the same score from both reviewers before conflict resolution as a proportion of the total number of trials. Domain scores were used to categorize studies into good, fair, and poor quality using the thresholds outlined by the Agency for Healthcare Research and Quality (AHRQ) [57].
Data Extraction and Meta-Analysis
Data including reference identification information, details of the participant characteristics such as age and target population, details of the intervention (intervention length, HIIT protocol, frequency, intensity, and exercise mode), methods of fitness or performance outcome testing, and results were extracted using a customized Microsoft Excel spreadsheet and Microsoft Word tables. Additionally, any concurrently measured, potentially influential physiological variables such as those relating to cardiac, muscular, or cellular metabolic adaptations, and measures of blood lactate accumulation or lactate clearance were also extracted. In cases where raw data necessary for meta-analysis was not directly reported but could be determined from the available information, it was calculated according to Cochrane recommendations [58]. Similarly, where individual trials included multiple intervention groups that met inclusion criteria, the groups were pooled according to Cochrane recommendations [58]. In cases where outcomes were only presented in figure format, the necessary data was extracted using WebPlotDigitizer software (version 4.5, Ankit Rohatgi, United States of America).
Where possible, pre-and post-intervention outcome data were meta-analyzed using the Meta-Essentials package (Erasmus University, the Netherlands) for Microsoft Excel [59] using differences for dependent groups and continuous data [60]. The dependent measures meta-analysis used a random-effects model and was based on Hedges’ g. The magnitude of the effect was inferred based on the exercise science-specific thresholds of small (0.20), moderate (0.60), and large (1.20) standardized mean differences, as outlined by Hopkins and colleagues [61]. Correlation coefficients for individual studies were calculated using mean outcome and change data by applying Follmann’s equation [62]. A mean of the calculated correlation coefficients from studies that provided the necessary data was used to impute a correlation coefficient for all other studies. Standardized mean differences were used to account for variation in the units of measure that were presented across different studies, however, wherever possible the most frequently reported unit of measure for each given outcome was included in the meta-analysis to maximize consistency. In cases where the first and second anaerobic thresholds were reported, the second threshold was used for inclusion in the meta-analysis.
Sensitivity Analyses and Methods for Exploring Heterogeneity
The primary research question was addressed by sub-grouping male and female data. Sensitivity analysis was then undertaken to check the effect of study quality and any observed outlying studies on total effect size and heterogeneity within the meta-analysis. Outlying studies were removed from the analysis if they were observed to have a poor fit with the remaining studies and an underlying methodological explanation for this was identified. Studies that were categorized as poor on the NOS were excluded for sensitivity analysis to assess the effect of study quality and subsequently excluded from all meta-analyses if the effect was deemed significant. An additional sensitivity analysis was undertaken on the primary analysis of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max to check the effects of the meta-analytical approach and to estimate raw mean differences for the pooled data. This analysis was undertaken in order to provide more practical estimates of baseline values and effects, as well as checking whether the use of raw mean differences over standardized mean differences would result in any changes in the overall findings. Data were pooled in Review Manager (RevMan) version 5.4.1 (The Cochrane Collaboration) using a random effects model and a raw mean difference directly comparing baseline absolute and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max for men and women, as well as pre-post measures for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (absolute and relative).
Potential sources of heterogeneity were explored through additional sub-grouping by the pre-determined population characteristics of baseline training status and mean group age, as well as by intervention type and length. Baseline training status was categorized as untrained, moderately trained, and well trained based on the population description by the authors of the primary studies. The grouping of studies into each training status category was confirmed by cross-checking the category against the mean baseline \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max, where available. In cases where the description of baseline training status was not clear within the primary study, grouping was informed by the baseline \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and the homogeneity with other studies in the grouping. Untrained populations were identified as previously sedentary or those not currently participating in regular exercise at baseline. Moderately trained populations included recreationally active individuals. Well-trained populations included those described as ‘well trained’, and elite, or semi-elite athletes. Sub-grouping by age was undertaken using the mean sample group age and categorized as (a) adults under 30 years; (b) participants aged 30–45 years, and (c) participants over 45 years of age. Sub-grouping into intervention type involved categorizing study data into HIIT (interventions using sub-maximal intensities) or SIT (supra-maximal/all-out intensities). Sub-grouping by intervention length involved categorizing study data into interventions ≤ 4 weeks, 5–9 weeks, and ≥ 10 weeks in duration.
Qualitative Synthesis
For outcomes where only a small number of trials reported data, and meta-analytical methods were deemed to be inappropriate, results were synthesized qualitatively by grouping various measures and reporting the relevant results of each study.
Assessing the Risk of Bias Across Studies
The risk of bias across studies was assessed using visual inspection of the funnel plots for the primary meta-analyses [63, 64]. The presence of publication bias was assumed if notable asymmetry was present within the funnel plot. Adjusted effect sizes were reported where relevant.
Results
Search Results and Study Characteristics
![Click to view full size Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart of the search and screening process.high-intensity interval training,maximal oxygen uptake HIIT O \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ 2max](https://europepmc.org/articles/PMC10799129/bin/40279_2023_1914_Fig1_HTML.jpg.jpg)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart of the search and screening process.high-intensity interval training,maximal oxygen uptake HIIT O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ 2max
| Study | Study type | Group | Females | Males | Combined | Population | NOS | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Age, y (± SD) | n | Age, y (± SD) | n | Age, y (± SD) | (Score/9) | Categorization AHRQ | ||||
| Astorino 2011 [] + Astorino 2012 [] [76] [66] | NRCT | SIT | 9 | 25.2 (3.1) | 11 | 25.3 (5.5) | Recreationally active men and women | 7 | Good | ||
| CON | 4 | 22.6 (3.1) | 5 | 23.0 (2.7) | |||||||
| Bagley 2016 [] + Bagley 2021 [] [77] [78] | NCT | SIT | 17 | 41 (SEM 3.2) | 24 | 38 (SEM 2.7) | Healthy adults (unhealthy subjects, or those involved in competitive sports or cycled for > 15 min/d for ≥ 3 d/wk were excluded) | 6 | Fair | ||
| Bornath 2022 [] [79] | NCT | HIIT | 15 | 23 (1) | 18 | 23 (2) | Recreationally active adults | 7 | Good | ||
| Bostad 2021 [] [80] | NCT | SIT | 9 | 6 | 15 | 21 (2) | Healthy untrained adults | 7 | Good | ||
| Cicioni-Kolsky 2013 [] [98] | RCT | HIIT | 9 | 18.4 (1.3) | 10 | 20.8 (3.8) | Recreationally and moderately trained individuals involved in a variety of sports | 8 | Good | ||
| SMIT | 14 | 18.6 (1) | 6 | 20.2 (3.1) | |||||||
| CON | 9 | 20.9 (4.4) | 7 | 19.7 (1.4) | |||||||
| Dalzill 2014 [] [82] | NCT (retrospective) | HIIT | 55 | 51.3 (8.7) | Metabolically healthy obeseNOTE: study included a metabolically unhealthy obese participant group (not extracted) | 6 | Poor | ||||
| Esbjörnsson Liljedahl 1996 [] [97] | NRCT | SIT | 10 | 25 (range 21–29) | 6 | 26 (range 23–30) | Recreationally active students at a College for Sports and Recreation Instructors | 7 | Good | ||
| CON | 5 | 24 (range 22–27) | 5 | 24 (range 23–26) | |||||||
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | NCT | HIIT | 8 | 30 (4.8) (range 26–34) | 9 | 29 (6.3) (range 24–34) | Trained to well-trained competitive cyclists and triathletes, aged 18–40 y | 8 | Good | ||
| Gillen 2014 [] [83] | NCT | SIT | 7 | 30 (10) | 7 | 29 (9) | Overweight and obese but otherwise healthy adults | 7 | Good | ||
| Hiam 2021 [] [84] | NCT | HIIT | 22 | 34.8 (7.0) | 74 | 31.2 (8.2) | Healthy males and healthy pre-menopausal females | 7 | Good | ||
| Hirsch 2021 [] [72] | NCT | HIIT | 10 | 36.80 (5.59) | 9 | 36.67 (5.96) | Overweight and obese but otherwise healthy adults (non-smokers, < 150 min/wk of moderate exercise, < 2 d/wk of resistance training, and no HIIT in the previous 12 wk) | 8 | Fair | ||
| Lepretre 2009 [] [85] | NCT | HIIT | 19 | 65.5 (5.4) | 16 | 64.6 (3.7) | 35 | 65.4 (4.9) | Healthy older adults | 7 | Fair |
| Liu 2021 [] [86] | RCT | SIT | 8 | 20.5 (1.4) | 8 | 20 (1.3) | Elite badminton players | 8 | Good | ||
| CON | 8 | 19.4 (1.5) | 8 | 21.5 (2.2) | |||||||
| Marterer 2020 [] [67] | NCT | HIIT | 11 | 24 (3) | 9 | 27 (5) | 20 | 26 (4) | Healthy trained adults | 6 | Fair |
| Menz 2015 [] [87] | RCT | HIIT | 5 | 25 (1) | 14 | 28 (3) | 19 | 27 (3) | Well-trained athletes (O63.7 ± 7.7 mL·kg·min. Normal exercise load: 9.5 ± 5.0 h/wk)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max−1−1 | 7 | Good |
| CON | 3 | 23 (1) | 13 | 25 (1) | 16 | 24 (2) | |||||
| Metcalfe 2012 [] [88] | RCT | REHIT | 8 | 24 (3) | 7 | 26 (3) | Sedentary but healthy adults | 8 | Good | ||
| CON | 8 | 21 (1) | 6 | 19 (1) | |||||||
| Metcalfe 2016 [] [68] | NCT | REHIT | 18 | 36 (9) | 17 | 33 (9) | Sedentary but healthy adults | 8 | Good | ||
| Molina-Hidalgo 2020 [] [69] | QRCT | HIIT (0.0% alcohol beer) | 7 | 23.4 (4) | 8 | 25.4 (8.1) | Healthy adults++NOTE: study included HIITbeer and HIITwater and vodka groups (not extracted). Participants self-selected to training or non-training condition | 8 | Good | ||
| HIIT (water) | 7 | 20.9 (2.7) | 9 | 26.9 (7.6) | |||||||
| CON | 7 | 19.9 (2.3) | 7 | 20.1 (2.9) | |||||||
| Mucci 2004 [] [70] | NCT | HIIT | 10 | 18.5 (0.7) | 12 | 18.4 (0.7) | 22 | 18.5 (0.5) | Non-elite sportsmen and sportswomen | 8 | Good |
| Phillips 2017 [] [89] | NRCT | 5-by-1 HIIT | 136 | 36 (9) | Sedentary overweight and obese but otherwise healthy adults | 6 | Poor | ||||
| 7-by-1 HIIT | 40 | 37 (10) | |||||||||
| CON | 13 | 31 (11) | |||||||||
| Sawashita 2009 [] [90] | NCT | High-intensity interval walking | 17 | 60.3 (SEM: 1.6) | 6 | 65.2 (SEM: 1.8) | 23 | 61.6 (SEM: 1.3) | Middle-aged and older (40–69 y), overweight and obese (BMI ≥ 23.6 kg/m), Japanese adults2NOTE: study included a high-interval walking and mild calorie restriction group (not extracted) | 5 | Poor |
| Scalzo 2014 [] [91] | NCT | SIT | 10 | 22 (SEM: 1) | 11 | 23 (SEM: 1) | Healthy recreationally active adults | 7 | Good | ||
| Schmitz 2019 [] [75] | NCT | Unmodified 4 × 30 s SIT | 7 | 10 | 17 | 22.0 (1.6) | Moderately trained university students (Physical Education) | 6 | Fair | ||
| Progressive 4–7 × 30 s SIT | 8 | 9 | 17 | 21.1 (1.8) | |||||||
| Schmitz 2020 [] [95] | NCT | 4 × 30:30 | 14 | 23.1 (1.4) | 7 | 22.1 (1.8) | Young healthy moderately trained university students (Physical Education) | 5 | Fair | ||
| 4 × 30:180 | 12 | 23.4 (4.4) | 5 | 23.6 (1.3) | |||||||
| Schubert 2017a [] + Schubert 2017b [] [71] [92] | QRCT | HIIT | 7 | 5 | Moderately active (> 120 min/wk of PA), healthy adults | 6 | Fair | ||||
| SIT | 7 | 5 | |||||||||
| CON | 3 | 3 | |||||||||
| Søgaard 2018 [] + Chrøis 2020 [] [93] [81] | NCT | HIIT | 11 | 63 (SEM 2) | 11 | 63 (SEM 1) | Older sedentary adults (inclusion criteria were age 55–75 years) | 7 | Good | ||
| Støren 2017 [] [94] | NCT | HIIT | 22 | 72 | 94 | 48.6 (18.2) | Healthy male and female matched for pre-testOrelative to age: typically, weekly low to moderate aerobic activity (0–2 h/wk)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | 6 | Fair | ||
| Weber 2002 [] [74] | NCT | HIIT | 7 | 22.7 (SEM 2.6) | 7 | 23.7 (SEM 1.6) | Untrained males and females | 8 | Good | ||
| Study | Session type | Exercise modality | Intervention length | Sessions/week or total | Interval training protocol | Session duration | Dose delivered vs dose received (fidelity of the intervention) |
|---|---|---|---|---|---|---|---|
| Astorino 2011 [] + Astorino 2012 [] [76] [66] | SIT | Cycle ergo | 2–3 wk | 6 × in total, separated by ≥ 2 d | Intervals: 4 × 30-s sprints Intensity: all-out ‘Wingate’ interval Recovery: 5-min passive | Not stated | All participants completed all requirements of the protocol |
| CON | N/A | Not stated | |||||
| Bagley 2016 [] + Bagley 2021 [] [77] [78] | SIT | Cycle ergo | 12 wk | 3 × /wk | Intervals: 4 × 20-s sprintsIntensity: ≈ 175%OV2maxRecovery: 2 min | ≈ 10 min | Participants maintained a training log to record workloads during training sessions. No further details |
| Bornath 2022 [] [79] | SIT | Battling ropes | 6 wk | 3 × /wk | Intervals: 10 × 30-sIntensity: > 85% HRmaxRecovery: 60 s | Not stated | Number of repetitions plus exercise intensity monitored during sessions (HR, RPE, and BLa) |
| Bostad 2021 [] [80] | SIT | Cycle ergo | 12 wk | 3 × /wk, separated by ≥ 1 d | Intervals: 2 × 20-s sprints Intensity: all-out Recovery: 2 min | ≈ 10 min | 28 ± 3 supervised sessions completed. No further details |
| Cicioni-Kolsky 2013 [] [98] | HIIT | Running on 200-m grass track | 6 wk | 2 × /wk | Intervals: 4 × 4 min → 5 × 4 min → 6 × 4 min (add interval every 2nd week) Intensity: 3000 m TT average pace Recovery: 1:1 work to rest ratio | Not stated | Only data of participants who completed all components of the training study were analyzed |
| SMIT | Running on 200-m grass track | 6 wk | 3 × /wk | Intervals: 7 × 30-s sprints adding 1 × sprint interval each week Intensity: 130% of 3000 m TT average pace Recovery: 150 s passive recovery | Not stated | ||
| Dalzill 2014 [] [82] | HIIT | Cycle ergo | 9 mo | 2–3 × /wk | Intervals: 15–30 s Intensity: 80% of maximal aerobic power Recovery: 15–30 s Sets: 2 × 10 min with 4 min passive recovery | ≈ 60 min | Adherence to exercise training sessions was 3.0 ± 1.1 and 2.7 ± 1.0 sessions/week for metabolically healthy and unhealthy obese groups, respectively |
| Esbjörnsson Liljedahl 1996 [] [97] | SIT | Cycle ergo | 4 wk | 3 × /wk | Intervals: 3 × 30-s sprints Intensity: all-out ‘Wingate’ interval Recovery: 20 min | Not stated | There was no significant difference between the sexes in relative training intensity. No further details |
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | HIIT | Cycle ergo | 6 wk | 1–3 × /wk 10 sessions total | Intervals: 10 × 90 s Intensity: 100% PPO Recovery: 60 s active recovery | Not stated | Training diaries were completed to ensure compliance and to compare between sexes. No between-sex differences were found for end HR, RPE or peak BLa measures across the HIIT sessions |
| Gillen 2014 [] [83] | SIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: 3 × 20 s sprints Intensity: all-out Recovery: 2 min | 10 min | Adherence to the training sessions was 100%. Relative peak and mean power output during first and last session did not differ between men and women |
| Hiam 2021 [] [84] | HIIT | Cycle ergo | 4 wk | 3 × /wk | Intervals: progression from 2 × 2 min → 16 × 2 min Intensity: 40–70% delta PPO—power at LT Recovery: 1 min at 60 W | Not stated | All participants trained under supervision. Intensity was individually determined from baseline graded exercise test. No further details |
| Hirsch 2021 [] [72] | HIIT | Cycle ergo | 8 wk | 2 × /wk | Intervals: Week 1: 6 × 1 min Week 2: 7 × 1 min Week 3: 8 × 1 min Week 4: 9 × 1 min Weeks 5–8: 10 × 1 min Intensity: 90% of max Wattage Recovery: 1-min rest | 12–20 min | All training sessions were supervised one-on-one. Mean compliance to the HIIT protocol was 96 ± 9% for the entire 8 wk. Completion of at least 13 sessions was considered compliant |
| Lepretre 2009 [] [85] | HIIT | Cycle ergo | 9 wk | 2 × /wk | Intervals: 6 × 1 min Intensity: 2nd ventilatory threshold Recovery: 4 min at 1st ventilatory threshold | 30 min | Details not reported |
| Lui 2021 [] [86] | SIT | Cycle ergo | 8 wk | 3 × /wk | Intervals: 5 × 30 s sprints Intensity: all-out Recovery: 5 min | Not stated | HR was monitored during training to obtain HR, time spent in %HRzones and training impulse. Mean and peak HR, total and effective training times were similar for men and womenmaxmax |
| Control | Running | 8 wk | Not stated | Continuous ‘Fartlek’ running at 65–79% HRmax | 40 min | ||
| Marterer 2020 [] [67] | HIIT | Cycle ergo | 6 wk | Week 1–3: 3 × /wk Week 4–6: 4 × /wk | Intervals: 4 × 4 minIntensity: 85–95% HRmaxRecovery: 2 min at 65–75% HRmax | Not stated | Session one was supervised to reinforce the protocol. HR was recorded during sessions and monitored by the test coordinator. Participants who did not complete > 30 of 31 HIIT sessions were excluded from analysis |
| Menz 2015 [] [87] | HIIT | Running on 400-m track | 3 wk | Week 1: 3 × /wk Week 2–3: 4 × /wk | Intervals: 4 × 4 minIntensity: 90–95% HRmaxRecovery: 4 min active recovery | Not stated | Sessions were supervised, and training data were recorded in a logbook. HR and RPE were monitored during sessions. All participants completed 11 sessions, except for one who completed 10 |
| Metcalfe 2012 [] [88] | SIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: Session 1: 1 × 10 s Sessions 2–3: 2 × 10 s Sessions 4–9: 2 × 15 s Sessions 10–18: 2 × 20 s Intensity: all-out Recovery: 3–4 min low intensity | 10 min in total | All training sessions were supervised. Mean adherence to the training program was 97%. Mean RPE from the whole training program was higher for women than men |
| Metcalfe 2016 [] [68] | SIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: Session 1: 1 × 10 s Sessions 2–3: 2 × 10 s Sessions 4–9: 2 × 15 s Sessions 10–18: 2 × 20 s Intensity: all-out Recovery: 3–4 min low intensity | 10 min in total | All training sessions were supervised. Mean adherence to the training programme was 98.5%. Mean RPE was 14 ± 2 with no significant differences between men and women |
| Molina-Hidalgo 2020 [] [69] | HIIT | Circuit training (e.g. horizontal rows, squats, push ups) | 10 wk | 2 × /wk Separated by > 48 h | Intervals: 2 × sets of 8 × exercises Intensity: 8–10 RPE Recovery (sets): time NER active recovery | 40 min → 65 min | Participants that did not attend ≥ 80% of sessions were not included in the analysis. Training sessions were supervised in groups of ≈8 and participants were continuously encouraged to reach the specific target intensities |
| CON | N/A | ||||||
| Mucci 2004 [] [70] | HIIT | Running | 8 wk | 3 × /wk | Sessions (each wk)Mon: 2 × sets of 13 × 5-s sprint at V/20-s recoverymaxWed: 2 × sets of 15 × 10 s at vVO+ 40% (V− vVO)/10-s recovery2maxmax2maxFri: 2 × sets of 6 × 30 s at vVO+ 40% (V− vVO)/90-s recovery2maxmax2maxRecovery (sets): 5 min | Not stated | The target running speeds were achieved by setting a covering distance during the work time defined in each training session (i.e., 5, 10, or 30 s). Participants who did not regularly attend sessions were excluded |
| Phillips 2017 [] [89] | 5-by-1 HIIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: 5 × 1 minIntensity: 100% VO2maxRecovery: 90 s | Not stated | Sessions were fully supervised. No further details |
| 7-by-1 HIIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: 7 × 1 minIntensity: 100% VOincreasing 10% every 2 wk2maxRecovery: 90 s | Not stated | ||
| CON | N/A | 6 wk | |||||
| Sawashita 2009 [] [90] | HIIT | Walking | 16 wk | ≥ 4 × /wk | Intervals: 5 × 3 minIntensity: 70–85% VO2maxRecovery: 3 min ≈40% VO2max | Not stated | Steps and intensity were monitored with an accelerometer with audio cues to signal the change in intensity during training. If targets were not met from accelerometer data, trainers encouraged participants to increase their efforts |
| Scalzo 2014 [] [91] | SIT | Cycle ergo | 3 wk | 9 sessions total Separated by 1–2 d | Intervals: 4–8 × 30 s Intensity: all-out Recovery: 4-min active recovery | Not stated | Details not reported |
| Schmitz 2019 [] [75] | HIIT | Running | 4 wk | 3 × /wk Separated by ≥ 1 d | Intervals: 4 × 30 s Intensity: all-out Recovery: 30-s active recovery | Not stated | The first and last training session were supervised and running speed was recorded. Reported adherence to training was 92.2 ± 12.35% for the HIIT group and 91.7 ± 11.28% for the proHIIT group |
| ProHIIT | Running | 4 wk | 3 × /wk Separated by ≥ 1 d | Intervals: 4 × 30 s increasing by 1 interval each week → 7 × 30 s Intensity: all-out Recovery: 30-s active recovery | Not stated | ||
| Schmitz 2020 [] [95] | SIT | Running on 200-m indoor track | 4 wk | 2 × /wk Separated by ≥ 2 d | Intervals: 4 × 30 s Intensity: all-out Recovery: 3-min active recovery | Not stated | Participants who completed < 6 of 8 training sessions were excluded from the analysis. Training sessions were controlled by at least two experienced trainers |
| SIT | Running on 200-m indoor track | 4 wk | 2 × /wk Separated by ≥ 2 d | Intervals: 4 × 30 s Intensity: all-out Recovery: 30-s active recovery | Not stated | ||
| Schubert 2017a [] + Schubert 2017b [] [71] [92] | HIIT | Cycle ergo | 4 wk | 3 × /wk | Intervals: Wk 1–2: 2 × 90 s; Wk 3–4: 4 × 90 s Intensity: 90% PPO Recovery: 1-min active recovery (10% PPO) | 16–20 min | All participants completed all 12 sessions over 4 wk. Average HR during sessions were monitored to determine intensity |
| SIT | Cycle ergo | 4 wk | 3 × /wk | Intervals: 3 × 20 s Intensity: all-out Recovery: 2-min active recovery (10% PPO) | 10–15 min | ||
| CON | N/A | 4 wk | |||||
| Søgaard 2018 [] + Chrøis 2020 [] [93] [81] | HIIT | Cycle ergo | 6 wk | 3 × /wk | Intervals: 5 × 1 minIntensity: 85% VOincreasing by 10% each interval2maxRecovery: 90-s active recovery (25 W) | Not stated | All sessions were completed by 18 participants. Three men missed one session and one woman missed two sessions. Men and women trained at a similar load |
| Støren 2017 [] [94] | HIIT | Treadmill or cycle ergo | 8 wk | 3 × /wk | Intervals: 4 × 4 minIntensity: 90–95% of HRmaxRecovery: 3-min active recovery at 70% HRmax | Not stated | Training sessions were supervised. HR was monitored to verify target intensity. Mean compliance to the intervention was 92% ± 4%, with no significant differences between men and women |
| Weber 2002 [] [74] | HIIT | Cycle ergo | 8 wk | 3 × /wk | Intervals: 3 × 2 minIntensity: 85% → 100% of the workload = 120% VO2peakRecovery: 6 min | Not stated | Peak HR recorded during training at weeks 1, 4 and 8 was not different between men and women |
| Outcome | Sub-group | Within-group effects | Heterogeneity | Between-group difference | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ntrials | nparticipants | %Δ ()σ | g | 95% CI | p | (%)I2 | Q | ()pQ | Q | df | p | |||
| Men vs women, total | ||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | Women | 19 | 265 | 11.16 (7.39) | 0.57 | (0.44–0.69) | 0 | 62.14 | 47.54 | 0 | ||||
| Men | 19 | 273 | 10.90 (5.75) | 0.57 | (0.42–0.72) | 0 | 78.8 | 84.91 | 0 | 0 | 1 | 0.965 | ||
| PPO | Women | 8 | 99 | 11.16 (5.99) | 0.56 | (0.32–0.80) | 0 | 75.84 | 28.97 | 0 | ||||
| Men | 8 | 143 | 8.22 (5.09) | 0.41 | (0.22–0.59) | 0 | 62.06 | 18.45 | 0.01 | 1.05 | 1 | 0.304 | ||
| WorkAT | Women | 5 | 79 | 8.07 (6.55) | 0.38 | (0.13–0.64) | 0.001 | 31.26 | 5.82 | 0.213 | ||||
| Men | 5 | 123 | 7.09 (7.17) | 0.38 | (0.11–0.64) | 0.002 | 29.85 | 5.7 | 0.223 | 0 | 1 | 0.964 | ||
| Men vs women, relativeO\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | ||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | Women | 16 | 205 | 11.35 (7.70) | 0.57 | (0.43–0.71) | 0 | 63.27 | 40.84 | 0 | ||||
| Men | 16 | 249 | 9.88 (4.92) | 0.55 | (0.38–0.71) | 0 | 80.73 | 77.85 | 0 | 0.04 | 1 | 0.845 | ||
| Men vs women, absoluteO\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | ||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | Women | 7 | 87 | 10.33 (6.30) | 0.56 | (0.28–0.83) | 0 | 80.33 | 30.5 | 0 | ||||
| Men | 7 | 91 | 11.34 (6.28) | 0.51 | (0.32–0.70) | 0 | 57.35 | 14.07 | 0.029 | 0.06 | 1 | 0.805 | ||
| Men vs women by baseline training status | ||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | Untrained | Women | 11 | 164 | 13.22 (8.49) | 0.63 | (0.48–0.78) | 0 | 56.81 | 23.15 | 0.01 | |||
| Men | 11 | 114 | 13.86 (5.23) | 0.66 | (0.48–0.85) | 0 | 68.34 | 31.59 | 0 | |||||
| Moderately trained | Women | 5 | 72 | 8.40 (6.12) | 0.33 | (0.15–0.51) | 0 | 34.48 | 6.11 | 0.191 | ||||
| Men | 5 | 130 | 4.37 (1.68) | 0.18 | (0.09–0.28) | 0 | 0 | 3.39 | 0.494 | |||||
| Well trained | Women | 3 | 29 | 8.23 (1.20) | 0.72 | (0.41–1.04) | 0 | 23.73 | 2.62 | 0.269 | ||||
| Men | 3 | 29 | 10.92 (1.14) | 0.86 | (0.86–0.87) | 0 | 0 | 0 | 1 | |||||
| All groups | 48.74 | 5 | 0 | |||||||||||
| PPO | Untrained | Women | 4 | 44 | 13.99 (6.73) | 0.77 | (0.36–1.18) | 0 | 79.57 | 14.68 | 0.002 | |||
| Men | 4 | 41 | 12.23 (3.61) | 0.6 | (0.31–0.89) | 0 | 54.58 | 6.61 | 0.086 | |||||
| Moderately trained | Women | 2 | 36 | 9.96 (5.25) | 0.35 | (0.01–0.68) | 0.036 | 54.31 | 2.19 | 0.139 | ||||
| Men | 2 | 84 | 5.86 (0.65) | 0.27 | (0.14–0.41) | 0 | 0 | 1 | 0.317 | |||||
| Well trained | Women | 2 | 19 | 6.71 (3.67) | 0.37 | (0.26–0.48) | 0 | 0 | 0.25 | 0.618 | ||||
| Men | 2 | 18 | 2.56 (1.52) | 0.17 | (0.15–0.19) | 0 | 0 | 0.01 | 0.927 | |||||
| All groups | 11.04 | 5 | 0.051 | |||||||||||
| Men versus women by group mean age | ||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | Under 30 y | Women | 10 | 93 | 9.49 (3.82) | 0.63 | (0.47–0.79) | 0 | 35.93 | 14.05 | 0.121 | |||
| Men | 10 | 95 | 11.54 (5.65) | 0.71 | (0.54–0.89) | 0 | 49.67 | 17.88 | 0.037 | |||||
| 30–45 y | Women | 5 | 81 | 10.63 (6.74) | 0.39 | (0.20–0.57) | 0 | 52.12 | 8.35 | 0.079 | ||||
| Men | 5 | 134 | 8.04 (6.78) | 0.4 | (0.04–0.75) | 0 | 88.73 | 35.51 | 0 | |||||
| Over 45 y | Women | 4 | 91 | 15.99 (13.52) | 0.68 | (0.35–1.00) | 0 | 72.45 | 10.89 | 0.012 | ||||
| Men | 4 | 44 | 12.88 (4.64) | 0.49 | (0.21–0.77) | 0 | 52.66 | 6.34 | 0.096 | |||||
| All groups | 8.6 | 5 | 0.126 | |||||||||||
| Outcome | Sub-group | Within-group effects | Heterogeneity | Between-group difference | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ntrials | nparticipants | %Δ ()σ | g | 95% CI | p | (%)I2 | Q | ()pQ | Q | df | p | ||||
| Men vs women, HIIT versus SIT | |||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | HIIT | Women | 11 | 177 | 11.00 (9.29) | 0.52 | (0.34–0.71) | 0 | 76.06 | 41.77 | 0 | ||||
| Men | 11 | 172 | 11.20 (5.54) | 0.6 | (0.37–0.82) | 0 | 85.98 | 71.32 | 0 | ||||||
| SIT | Women | 9 | 96 | 10.86 (4.19) | 0.59 | (0.46–0.71) | 0 | 0 | 6.77 | 0.562 | |||||
| Men | 9 | 93 | 9.82 (6.32) | 0.46 | (0.27–0.65) | 0 | 52.58 | 16.87 | 0.04 | ||||||
| All groups | 1.36 | 3 | 0.716 | ||||||||||||
| PPO | HIIT | Women | 7 | 131 | 8.26 (5.50) | 0.48 | (0.28–0.68) | 0 | 69.41 | 19.61 | 0.003 | ||||
| Men | 7 | 85 | 10.10 (5.69) | 0.41 | (0.20–0.62) | 0 | 66.08 | 17.69 | 0.007 | ||||||
| SIT | Women | 2 | 14 | 7.16 (1.14) | 0.9 | (0.14–1.66) | 0.011 | 73.79 | 3.82 | 0.051 | |||||
| Men | 2 | 12 | 16.09 (2.71) | 0.33 | (− 0.01 to 0.68) | 0.033 | 9.94 | 1.11 | 0.292 | ||||||
| All groups | 2.34 | 3 | 0.506 | ||||||||||||
| Men vs women by intervention length | |||||||||||||||
| O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | ≤ 4 weeks | Women | 4 | 55 | 5.82 (2.37) | 0.25 | (0.11–0.39) | 0 | 0 | 2.2 | 0.532 | ||||
| Men | 4 | 106 | 3.97 (1.63) | 0.16 | (0.05–0.27) | 0.003 | 0 | 2.51 | 0.474 | ||||||
| 5–9 weeks | Women | 10 | 109 | 9.39 (4.23) | 0.55 | (0.40–0.70) | 0 | 29.97 | 12.85 | 0.169 | |||||
| Men | 10 | 103 | 11.24 (3.64) | 0.67 | (0.50–0.85) | 0 | 58.7 | 21.79 | 0.01 | ||||||
| ≥ 10 weeks | Women | 5 | 101 | 18.98 (9.42) | 0.79 | (0.63–0.94) | 0 | 19.55 | 4.97 | 0.29 | |||||
| Men | 5 | 64 | 15.76 (6.27) | 0.66 | (0.32–1.00) | 0 | 80.41 | 20.42 | 0 | ||||||
| All groups | 59.35 | 5 | 0 | ||||||||||||
| References | Measurement | Outcome (units) | Sex, baseline | Δ M | Δ F | Interaction |
|---|---|---|---|---|---|---|
| Maximal oxygen uptake | ||||||
| Astorino 2011 [] + Astorino 2012 [] [76] [66] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NS | + | + | NS |
| O(L/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | M > F (< 0.05)p | + (5.9 ± 3.9%) | + (6.8 ± 7.1%) | NS (= 0.58)p | ||
| Bagley 2016 [] + Bagley 2021 [] [77] [78] | Cycle ergo test, indirect calorimetry | O(ml/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | (= 0.005)p | + (6.0%) | + (18.7%) | F > M (= 0.049)p |
| O(L/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | (< 0.001)p | + | + | F > M (= 0.009)p | ||
| Bornath 2022 [] [79] | Arm cycle test, indirect calorimetry (Astrand protocol) | O—arms (mL/kg/min), 3 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (ES: < 0.45;< 0.004)p | + (ES: 0.67;< 0.001)p | NER |
| O–arms (mL/kg/min), 6 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (ES: 0.66;< 0.001)p | + (ES: 0.48;= 0.001)p | NER | ||
| Bostad 2021 [] [80] | Cycle ergo test, indirect calorimetry | O(L/min), 2 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | NER | + (= 0.03)p | NS | M > F (< 0.01)p |
| O(L/min), 6 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | + (< 0.01)p | + (< 0.01)p | NS | |||
| O(L/min), 12 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | + (< 0.01)p | + (< 0.01)p | NS | |||
| Dalzill 2014 [] [82] | Incremental treadmill test | O(METs)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | M > F (< 0.001)p | + (< 0.0001)p | + (< 0.0001)p | NS |
| Gillen 2014 [] [83] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peakaO(L/min; baseline only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | NS (≤ 0.05)p | + (12%;< 0.001)p | + (12%;< 0.001)p | NS |
| Hiam 2021 [] [84] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | M > F (= 0.04)p | NER | NER | NS (= 0.48)p |
| Hirsch 2021 [] [72] | Cycle ergo test, indirect calorimetry | O(mL/kg/min), 0–4 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | M > F (= 0.03)p | NS (6.8%) | NS (− 0.5%) | NS |
| O(mL/kg/min), 4–8 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | NS (12.7%) | + (16.6%;< 0.05)p | NS | |||
| O(mL/kg/min), 0–8 wk\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | + (19.5%;< 0.05)p | + (16.1%;< 0.05)p | NS | |||
| Lepretre 2009 [] [85] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | M > F (< 0.05)p | + (14.9%;< 0.001)p | + (14.5%;< 0.001)p | NS |
| Liu 2021 [] [86] | Treadmill test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NER | + (ES: 1.14;< 0.05)p | + (ES: 1.28;< 0.05)p | NER |
| Marterer 2020 [] [67] | Cycle ergo test, indirect calorimetry | O—legs (mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NER | + (< 0.001)p | + (= 0.002)p | NS (= 0.088)p |
| O—legs (mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NER | + (9.96%;< 0.001)p | + (7.95%;= 0.002)p | M > F (= 0.007)p | ||
| Arm cycle test, indirect calorimetry | O—arms (mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NS | NS | NS (= 0.267)p | |
| O—arms (mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (= 0.031)p | NS | NS (= 0.134)p | ||
| Menz 2015 [] [87] | Treadmill test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NER | NER | NS, data pooled |
| O(mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NER | NER | NS, data pooled | ||
| Metcalfe 2012 [] [88] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | M > F (< 0.001)p | + (15.0%;< 0.01)p | + (12.0%;< 0.01)p | NS |
| Metcalfe 2016 [] [68] | Cycle ergo test, Douglas bag method | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | M > F (= 0.010)p | + (< 0.001)p | + (< 0.001)p | NS (= 0.926)p |
| O(L/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | M > F (< 0.001)p | + (< 0.001)p | + (< 0.001)p | NS (= 0.402)p | ||
| Molina-Hidalgo 2020 [] [69] | Treadmill test, indirect calorimetry (modified Balke) | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NER | + (< 0.05)p | + (< 0.05)p | NER |
| O(mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NER | + (< 0.05)p | + (< 0.01)p | NER | ||
| Mucci 2004 [] [70] | Multi-stage running test, portable gas analysis | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | M > F (< 0.05)p | + (10.0%;< 0.001)p | + (7.8%;< 0.01)p | NS |
| Phillips 2017 [] [89] | Cycle ergo test, indirect calorimetry | O(mL/kg/min; Δ% only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NER | NER | NS |
| O(L/min; 5-by-1 HIIT)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (0.32 ± 0.3 L/min) | + (0.19 ± 0.2 L/min) | M > F (< 0.001)p | ||
| Sawashita 2009 [] [90] | Estimated from graded walking test, triaxial accelerometer and ECG | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | NER | + (< 0.001) | + (< 0.001) | NS |
| Scalzo 2014 [] [91] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | NS | + (0.6 mL/kg/min;= 0.002)p | + (3.0 mL/kg/min;= 0.002)p | NS (= 0.287)p |
| Schmitz 2020 [] [95] | Estimated from maximal running speed (Léger and Boucher equation) | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NER | NER | NER, baseline only |
| Schubert 2017a [] + Schubert 2017b [] [71] [92] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxaO(L/min; pooled only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | NER | NER | NER, individual data presented |
| Søgaard 2018 [] + Chrøis 2020 [] [93] [81] | Cycle ergo test, indirect calorimetry | O(mL/kg/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | M > F (< 0.012)p | + (= 0.024)p | + (= 0.024)p | NS (= 0.277)p |
| O(mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2maxa | M > F (< 0.001)p | + (= 0.030)p | + (= 0.030)p | NS (= 0.473)p | ||
| Støren 2017 [] [94] | Treadmill or cycle ergometer test, indirect calorimetry | O(mL/kg/min; pooled only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (4.1 ± 2.5 mL/kg/min;< 0.001)p | + (4.2 ± 2.5 mL/kg/min;< 0.001)p | NS (= 0.300)p |
| O(L/min; pooled only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER | + (10.8 ± 8.1%;< 0.001)p | + (13.8% ± 10.0%;< 0.001)p | NER | ||
| Weber 2002 [] [74] | Cycle ergo test, indirect calorimetry | O(mL/kg/min, baseline only)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | M > F (< 0.05)p | NER | NER | NER |
| O(L/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peaka | M > F (< 0.001)p | + (7.9 ± 2.0%;< 0.01)p | NS (2.9 ± 1.5%) | M > F (< 0.05)p | ||
| References | Measurement | Outcome (units) | Sex, baseline | Δ M | Δ F | Interaction |
|---|---|---|---|---|---|---|
| Peak power output from incremental testing | ||||||
| Bostad 2021 [] [80] | Cycle ergo test, indirect calorimetry | (W; for ExRx only)Wpeak | NER | NER | NER | NER |
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | Cycle ergo test, earlobe capillary blood sampling | Absolute PPO (W)a | M > F (< 0.001)p | + (= 0.05)p | + (= 0.05)p | NS |
| Relative PPO (W·kgand W·kg)−1−0.32 | M > F (< 0.001)p | + (= 0.04)p | + (= 0.04)p | NS | ||
| Gillen 2014 [] [83] | Cycle ergo test, indirect calorimetry | Maximal workload (W; baseline) | M > F (≤ 0.05)p | + (14%;< 0.001)p | + (14%;< 0.001)p | NS |
| Relative PPO (W/kg FFM)a | NER | + (0.9 W/kg FFM;≤ 0.05)p | + (1.8 W/kg FFM;≤ 0.05)p | NER | ||
| Relative MPO (W/kg FFM) | NER | + (1.6 W/kg FFM;≤ 0.05)p | + (3.0 W/kg FFM;≤ 0.05)p | NER | ||
| Hiam 2021 [] [84] | Cycle ergo test, indirect calorimetry | PPO (W/kg)a | M > F (= 0.030)p | NER | NER | NS (= 0.650)p |
| Lepretre 2009 [] [85] | Cycle ergo test, indirect calorimetry | MTP (W)a | M > F (≤ 0.05)p | + (< 0.001)p | + (< 0.001)p | NS |
| Marterer 2020 [] [67] | Cycle ergo or arm cycle test, earlobe capillary blood sampling | PPO—legs (W)a | NER | + (= 0.033)p | + (= 0.026)p | NS (= 0.562)p |
| PPO—arms (W) | NER | NS (= 0.176)p | NS (= 0.498)p | NS (= 0.563)p | ||
| Phillips 2017 [] [89] | Incremental cycle ergo test | PPO/W(W; pooled only)max | NER | NER | NER | NER |
| Schubert 2017a [] + Schubert 2017b [] [71] [92] | Cycle ergo test, highest workload completed for 60 s | PPO (W)a | NER | NER | NER | NER, individual data presented |
| Søgaard 2018 [] + Chrøis 2020 [] [93] [81] | Cycle ergo test, indirect calorimetry | Maximum workload (W)a | M > F (< 0.001)p | + (31 W;< 0.001)p | NS (9 W) | M > F (= 0.004)p |
| Støren 2017 [] [94] | Treadmill or cycle ergometer test, indirect calorimetry | Work performance (W) | NER | + (24.5 ± 34.4%;< 0.001)p | + (23.8 ± 43.7%;< 0.001)p | NS (= 0.980)p |
| Weber 2002 [] [74] | Cycle ergo test, indirect calorimetry | PPO (W)a | M > F (< 0.001)p | + (10.7 ± 2.0%;< 0.01)p | + (11.2 ± 1.1%;< 0.01)p | NS |
| Threshold power | ||||||
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | Cycle ergo test, earlobe capillary blood sampling | LTpower output (W)2a | M > F (< 0.001)p | NS | NS | NS |
| Hiam 2021 [] [84] | Cycle ergo test, indirect calorimetry | Power output at LT (W/kg)a | M > F (= 0.040)p | NER | NER | NS (= 0.410)p |
| Lepretre 2009 [] [85] | Cycle ergo test, indirect calorimetry | Power at VT(W)1 | M > F (≤ 0.05)p | + (29.0%;< 0.001)p | + (32.5%< 0.001)p | NS |
| Power at VT(%MTP)1 | NS | + (12.0%;< 0.001)p | + (9.0%;< 0.001)p | NS | ||
| Power at VT(W)2a | M > F (≤ 0.05)p | + (< 0.001)p | + (< 0.001)p | NS | ||
| Power at VT(%MTP)2 | M > F (≤ 0.05)p | NS | NS | NS | ||
| Marterer 2020 [] [67] | Cycle ergo or arm cycle test, earlobe capillary blood samplingLT defined as 4 mmol/L of BLa | Power output at LT—legs (W/kg) | NER | NS (= 0.291)p | NS (= 0.059)p | NS (= 0.878)p |
| Power output, at LT—legs (W)a | NER | NS (= 0.301)p | + (= 0.054)p | NS (= 0.962)p | ||
| Power output at LT—arms (W/kg) | NER | NS (= 0.714)p | NS (= 0.195)p | NS (= 0.384)p | ||
| Power output, at LT—arms (W) | NER | NS (= 0.580)p | NS (= 0.182)p | NS (= 0.178)p | ||
| Schmitz 2019 [] [75] | Incremental running test, earlobe capillary blood sampling | Speed at LT (m/s), pooled HIIT + proHIITa | NER | + (0.13 m/s) | + (0.10 m/s) | NS (= 0.09)p |
| Schmitz 2020 [] [95] | Incremental running test, capillary blood sampled rest + immediate post | Speed at LT (km/h; baseline only) | M > F (< 0.001)p | NER | NER | NER |
| References | Measurement | Outcome (units) | Sex, baseline | Δ M | Δ F | Interaction |
|---|---|---|---|---|---|---|
| Threshold oxygen uptake | ||||||
| Hirsch 2021 [] [72] | Cycle ergo test, indirect calorimetry | VT (L/min), 0–4 weeks | Main effect | NS | NS | NS |
| VT (L/min), 4–8 weeks | (= 0.004)p | NS | + (< 0.05)p | NS | ||
| VT (L/min), 0–8 weeks | + (< 0.05)p | NS | NS | |||
| Lepretre 2009 [] [85] | Cycle ergo test, indirect calorimetry | VT(%O)12peak\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙ | M > F (= 0.054)p | + (= 0.011)p | + (= 0.011)p | NS |
| VT(%O)22peak\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙ | NS (= 0.362)p | NS (= 0.362)p | NS (= 0.362)p | NS | ||
| Liu 2021 [] [86] | Treadmill test, indirect calorimetry | VT (%O)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | NER (M: 74.0%; F: 75.0%) | + (11.0%;< 0.05)p | + (7.0%;< 0.05)p | NER |
| VT (mL/min) | NER | + (19.0%;< 0.05)p | + (11.0%;< 0.05)p | NER | ||
| Marterer 2020 [] [67] | Cycle ergo test, earlobe capillary blood sampled end of each stage | Oat LT—legs (mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2 | NER | NS (= 0.097)p | NS (= 0.058)p | NS (= 0.427)p |
| Oat LT—legs (mL/min/kg)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2 | NER | NS (= 0.088)p | NS (= 0.249)p | NS (= 0.960)p | ||
| Arm cycle test, earlobe capillary blood sampled end of each stageLT defined as 4mmol/L of BLa | Oat LT—arms (mL/min)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2 | NER | NS (= 0.859)p | NS (= 0.191)p | NS (= 0.296)p | |
| Oat LT—arms (mL/min/kg)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2 | NER | NS (= 0.844)p | NS (= 0.296)p | NS (= 0.465)p | ||
| Wingate power | ||||||
| Astorino 2011 [] + Astorino 2012 [] [76] [66] | Wingate test (repeated; two tests performed with 5 min of active recovery in between) | Maximal power (W/kg; pooled) | M > F (< 0.05)p | + (10.5%;< 0.05)p | + (9.1%;< 0.05)p | NS |
| Mean power (W/kg; pooled) | M > F (< 0.05)p | + (10.4%;< 0.05)p | + (10.9%;< 0.05)p | NS | ||
| Minimum power (W/kg; pooled) | NS | + (14.9%;< 0.05)p | + (9.5%;< 0.05)p | NS | ||
| Esbjörnsson Liljedahl 1996 [] [97] | Wingate test (repeated; three tests performed with a 20-min rest in between) | Maximal power (W), 1st test | NER | NS | + (6.0%;< 0.01)p | NS (< 0.06)p |
| Maximal power (W), 2nd test | NER | NS | NS | NS | ||
| Maximal power (W), 3rd test | NER | NS | NS | NS | ||
| Mean power (W), 1st test | NER | NS | + (10.0%;< 0.01)p | F > M (< 0.05)p | ||
| Mean power (W), 2nd test | NER | NS | + (6.0%;< 0.05)p | F > M (< 0.05)p | ||
| Mean power (W), 3rd test | NER | NS | + (4.0%;< 0.05)p | NS | ||
| Absolute power difference between M and F, mean of 3 tests | M > F (47.0%) | N/A | N/A | Post: M > F (38.0%;< 0.03)p | ||
| Fatigue and speed decrement | ||||||
| Astorino 2011 [] + Astorino 2012 [] [76] [66] | Wingate test (repeated; two tests performed with 5 min of active recovery in between) | Fatigue index (%; pooled) | M > F (M: 55.2%; F: 47.3%;< 0.05)p | NS (− 3.3%) | NS (0.0%) | NS |
| Scalzo 2014 [] [91] | The mean power from sprints during sessions 1 and 9 | Fatigue index (%), session 1–9 | NS (M: 28.0%; F: 13.0%;< 0.066)p | – (12%) | – (3%) | NS (= 0.066)p |
| Schmitz 2020 [] [95] | Incremental running test | Maximal speed (km/h; baseline only) Repeated sprint speed decrement, 4 × 30:30 Repeated sprint speed decrement, 4 × 30:180 | M > F (< 0.001)p | NER | NER | NER |
| NER | NS | – (3.4%;= 0.004)p | F > M (= 0.0038)p | |||
| NER | NS | NS | NS | |||
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | Cycle ergo test | Incremental time to fatigue (min) | F > M (< 0.01)p | + (1.8%;= 0.01)p | + (5.1%;= 0.01)p | NS |
| Weber 2002 [] [74] | Timed cycling test to fatigue at 120%O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak | Time to fatigue (s), Δ pre-mid training | NS | + (30.6 ± 3.4%;< 0.01)p | + (29.0 ± 3.2%;< 0.01)p | NER |
| Time to fatigue (s), Δ mid-post training | NS | + (12.4 ± 3.7%;< 0.05)p | + (9.6 ± 3.9%;< 0.05)p | NER | ||
| Time trials, maximal performance, and sprint ability | ||||||
| Bostad 2021 [] [80] | Average power output from all sprints and all training sessions | Sprint power output (%)Wpeak | N/A | N/A | N/A | NS (M: 237% W; F: 222% W;= 0.25)peakpeakp |
| 2 kJ/kg body weight cycle ergo time trial (distance NER) | Time trial completion, 2 wk | NER | – (< 0.01)p | – (< 0.01)p | NER, pooled only | |
| Time trial completion, 6 wk | – (= 0.14)p | – (= 0.14)p | ||||
| Time trial completion, 12 wk | – (< 0.01)p | – (< 0.01)p | ||||
| Cicioni-Kolsky 2013 [] [98] | Maximal, 640 m repeated sprint ability test (sum of six sprints) | 40-m maximal sprint (s), HIIT | NER | NS (1.28%;= 0.091)p | – (1.95%;= 0.013)p | NS (HIIT + SMIT,= 0.680)p |
| 40-m maximal sprint (s), SMIT | NER | – (2.99%;= 0.010)p | – (3.73%;< 0.001)p | |||
| 2 kJ/kg body weight cycle ergometer time trial | Sum of six sprints (s), HIIT | NER | – (2.86%;= 0.020)p | – (4.90%;= 0.001)p | NS (HIIT + SMIT,= 0.593)pF > M (HIIT + SMIT,= 0.012)p | |
| Sum of six sprints (s), SMIT | NER | – (5.16%;< 0.001)p | – (7.89%;< 0.001)p | |||
| 3000-m time-trial (s), HIIT | NER | – (7.35%;= 0.022)p | – (7.73%;= 0.001)p | |||
| 3000-m time-trial (s), SMIT | NER | – (5.88%;< 0.035)p | – (9.50%;< 0.001)p | |||
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | 40km time trial on a cycle ergometer | Time trial time (min) | F > M (< 0.01)p | – (1.70%;< 0.01)p | – (2.69%;< 0.01)p | NS (= 0.10)p |
| Time trial power output (W) | M > F (< 0.01)p | + (4.96%;< 0.01)p | + (7.49%;< 0.01)p | NS (= 0.14)p | ||
| Incremental cycle testLTdetermined using the Dmethod2max | Correlational analysis for Δ LTpower output2 | N/A | NS (Δ time trial performance; r= 0.07;= 0.49)2p | + (related to Δ time trial performance r= 0.77;= 0.004)2p | N/A | |
| Correlational analysis and Δ LTBLa, Δ absolute + relative PPO, Δ incremental time to fatigue2 | N/A | NS (Δ time trial performance for all) | NS (Δ time trial performance for all) | N/A | ||
| Liu 2021 [] [86] | YO-YO IR2 intermittent recovery test, 40-m running spaced by 10-s active rest (20-m course) | YO-YO IR2, or distance (m) | NER | + (ES: 0.68;< 0.05)p | + (ES: 0.68;< 0.05)p | NER |
| Mucci 2004 [] [70] | 60-m running speed field test, 20-m intervals with photocells at every 20 m | Maximal running speed,(m/s; max from 3 tests)Vmax | M > F (< 0.001)p | NS | NS | NER |
| Speed atO,O(m/s)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max2maxv | M > F (< 0.05)p | + (< 0.01)p | + (< 0.001)p | NER | ||
| Scalzo 2014 [] [91] | The mean power from repeated sprints during sessions 1 and 9 | Absolute mean power from 4 sprints, sessions 1 and 9 (W) | M > F (all< 0.001 except 4th sprint, session 1, NS)p | + 3rd sprint session 9 vs 1 only (= 0.004)p | NS for all | M > F (= 0.049)p |
| Relative mean power from sprints, sessions 1 and 9 (W/kg) | NS (= 0.301)p | NS | NS | NS (= 0.120)p | ||
| 40-km time trial on a stationary cycle ergometer | Time to cycle 40 km (min) | F > M (= 0.004)p | NS | NS | NS (= 0.269)p | |
| Schmitz 2019 [] [75] | Incremental running test | Maximal speed (m/s) | NER | NER | NER | NER, pooled only |
| Schmitz 2020 [] [95] | Incremental running test | Maximal speed (km/h; baseline only) | M > F (< 0.001)p | NER | NER | NER, baseline only |
| References | Measurement | Outcome (units) | Sex, baseline | Δ M | Δ F | Interaction |
|---|---|---|---|---|---|---|
| Blood lactate measures | ||||||
| Bornath 2022 [] [79] | BLa (pre- and post-) for 9th and 18th HIIT sessions=Δwithin session change | BLa, Δ from rest–imm post, 9th | NS for rest | + (ES: 0.95;< 0.001)p | + (ES: 0.84;< 0.001)p | NER |
| BLa, Δ from rest–imm post 18th | NS for imm post | + (ES: 0.95;< 0.001)p | + (ES: 0.88;< 0.001)p | NER | ||
| BLa, Δ from imm–5 min post, 9th | NS for 5 min post | – (ES: 0.21;= 0.048)p | NS | NER | ||
| BLa, Δ from imm–5 min post, 18th | N/A | – (ES: 0.29;= 0.017)p | – (ES: 0.53;< 0.001)p | NER | ||
| Fisher 2017 [] + Hoffmann 2021 [] [96] [73] | Incremental cycle test, earlobe blood samplingLTdetermined with Dmethod2max | LTBLa (mmol/L)2 | NS | NS | NS | NS (= 0.19)p |
| Lepretre 2009 [] [85] | Maximal incremental cycle ergo test, capillary blood sampling | BLa (mmol 100 mL) same absolute intensity (MTP pre-)−1 | M > F (< 0.05)p | – (45.03%;< 0.05)p | – (21.24%;< 0.05)p | NER |
| BLa (mmol 100 mL) same relative intensity (MTP pre- vs post-)−1 | M > F (< 0.05)p | NS | NS | NER | ||
| Liu 2021 [] [86] | Treadmill test, BLa tested at rest, 0-, 1-, 3-, 5-, 7-, and 10-min post-test | Lactate clearance rate (%) | NER | + (ES: 2.26;< 0.05)p | + (ES: 1.10;< 0.05)p | NER |
| Marterer 2020 [] [67] | Cycle or arm cycle ergo test, earlobe blood sampled end of each stageLT defined as 4 mmol/L BLa | Maximal BLa—legs (mmol/L) | NER | NS (− 6.56%;= 0.083)p | + (13.33%;= 0.017)p | F > M (= 0.003)p |
| Maximal BLa—arms (mmol/L) | NER | NS (= 0.214)p | NS (= 0.920)p | NS (= 0.470)p | ||
| Mucci 2004 [] [70] | Multi-stage running test, fingertip blood sampled pre- and post | Post-test BLa (mmol/L) | NS | NS | + (< 0.05)p | F > M (< 0.05)p |
| Weber 2002 [] [74] | BLa during session 1, wk 1 [baseline] and session 3, wks 4 [mid] and 8 [post] | BLa, resting (mmol/L) | M > F | NER | NER | |
| BLa, 3-min post-session (mmol/L) | M > F (< 0.01)p | + (9.6 ± 3.0%;< 0.05)p | + 9.6 ± 4.6%;< 0.05)p | NS | ||
| BLa, 3-min post-timed cycle (mmol/L) | M > F (< 0.01)p | – (< 0.05)p | – (< 0.05)p | NER | ||
| Cellular and muscular adaptations | ||||||
| Bagley 2016 [] + Bagley 2021 [] [77] [78] | Magnetic resonance imaging and isokinetic dynamometer | Quadriceps CSA (cm)2 | M > F (< 0.001)p | + (4.06%;= 0.023)p | + (5.82%;= 0.023)p | NS (= 0.140)p |
| Absolute MVC torque (Nm) | M > F (< 0.001)p | + (2.76%;= 0.079)p | + (5.62%;= 0.079)p | NS (= 0.385)p | ||
| Relative MVC torque (Nm·cm)−2 | NS (= 0.248)p | NS (= 0.712)p | NS (= 0.712)p | NS (= 0.705)p | ||
| Quadriceps fatigue index (%) | NS (= 0.282)p | + (7.67%;= 0.048)p | + (15.88%;= 0.048)p | NS (= 0.127)p | ||
| Esbjörnsson Liljedahl 1996 [] [97] | Muscle needle biopsy | Type II fiber CSA (μm)2 | M > F (< 0.01)p | NS | + (17%;< 0.05)p | F > M (< 0.01)p |
| Type II fiber (%) | NS | NS | NS | NS | ||
| % and CSA of other fiber types | NS | NS | NS | NS | ||
| Glycogen content | NS | NS | + (< 0.01)p | F > M (< 0.05)p | ||
| Total creatine content | NS | + (< 0.05)p | NS | M > F (< 0.05)p | ||
| Lactate dehydrogenase activity | M > F (< 0.05)p | + (< 0.05)p | + (< 0.05)p | NS | ||
| PFK, CS or HAD | NS | NS | NS | NS | ||
| Gillen 2014 [] [83] | Muscle biopsy, Western blotting | CS activity | NS | + | + | NS |
| β-HAD activity | F > M (< 0.05)p | + | NS | M > F (< 0.05)p | ||
| COX IV protein content | NS | + | + | NS | ||
| GLUT4 protein content | NS | + (138%;< 0.01)p | + (23%;< 0.01)p | M > F (< 0.05)p | ||
| Søgaard 2018 [] + Chrøis 2020 [] [93] [81] | Muscle biopsy, Western blotting | Mitochondrial respiratory capacity: | ||||
| Coupled | NS | + (< 0.001)p | NS | M > F (= 0.003)p | ||
| Uncoupled | NS | + (< 0.001)p | NS | M > F (= 0.003)p | ||
| CS activity | NS | + (< 0.001)p | + (= 0.013)p | NS | ||
| Adenosine diphosphate sensitivity | NS | – (= NER)p | – (= NER)p | NS (= 0.096)p | ||
| Creatine kinase content | NS | NS | NS | NS | ||
| Muscle glycogen content | NS | + (= 0.001)p | + (= 0.001)p | NS | ||
| GLUT4 | NS | + (< 0.050)p | + (< 0.050)p | NER | ||
| Glycogen synthase | NS | + (= 0.001)p | + (= 0.001)p | NER | ||
| Hexokinase II | NS | + (< 0.050)p | + (< 0.050)p | NER | ||
| Protein expression (multiple) | NS | Varied | Varied | NS | ||
| Scalzo 2014 [] [91] | Muscle biopsy, DO labelling (heavy water), Western blotting2 | Muscle mitochondrial biogenesis Muscle protein synthesis CS protein content COX IV protein content PGC1α protein content | NERM > F (< 0.001)pNSF > MNS | + (= NER)p+ (= NER)p+ (< 0.050)pNS+ (< 0.050)p | NERNER+ (< 0.050)pNS+ (< 0.050)p | M > F (= 0.056)pM > F (= 0.056)pNERNSNS |
| Central cardiorespiratory adaptations (other thanO)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max | ||||||
| Astorino 2011 [] [76] | Cycle ergo test, indirect calorimetry | CO(L/min)V2max | M > F (< 0.05)p | + (< 0.050)p | + (< 0.050)p | M > F (< 0.050)p |
| RERmax | NS | NS | NS | NS | ||
| HR(bpm)peak | NS | NS | NS | NS | ||
| VE(L/min)max | M > F (< 0.05)p | NS | NS | NS | ||
| Oxygen pulse (mL/beat) | M > F (< 0.05)p | + (< 0.050)p | + (< 0.050)p | NS (= 0.30)p | ||
| Bostad 2021 [] [80] | Cycle ergo test, indirect calorimetryInert gas rebreathing test, approx. 20 min postOtest\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peakPeak cardiac index calculated as Q/body surface areapeak | , 6 weeksQpeak | NER | + (< 0.01)p | NS | NER |
| , 12 weeksQpeak | NER | + (10%;< 0.01)p | NS (+ 0.6%;= 0.96)p | M > F (< 0.01)p | ||
| SV, 6 weekspeak | NER | + (< 0.01)p | NS | NER | ||
| SV, 12 weekspeak | NER | + (< 0.01)p | NS | M > F (< 0.01)p | ||
| Peak cardiac index, 6 weeks | NER | + (< 0.01)p | NS | NER | ||
| Peak cardiac index, 12 weeks | NER | + (< 0.01)p | NS | M > F (< 0.01)p | ||
| a-O, 6 weeks\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2diff | NER | + (< 0.05)p | + (< 0.05)p | NER | ||
| a-O, 12 weeks\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2diff | NER | + (< 0.01)p | + (< 0.01)p | NS (= 0.98)p | ||
| HR(bpm)peak | NER | NS | NS | NS (= 0.13)p | ||
| Correlational analysis, ΔO,, or calculated peak a-O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peakpeak2diffQ | N/A | NS correlation to Δ time to test completion | NS correlation to Δ time to test completion | N/A | ||
| Lepretre 2009 [] [85] | Maximal incremental cycle ergo test with indirect calorimetry | VE(L/min)max | M > F (< 0.05)p | + (7.75%;< 0.05)p | + (16.93%;< 0.05)p | NER |
| Mucci 2004 [] [70] | Multi-stage running test, portable gas analysis and fingertip blood sampled pre- and post>EIH defined as a decrease of4% in oxygen saturation during the last stage of exercise testing | VE(L/min)max | M > F (< 0.01)p | + (5.77%;< 0.05)p | NS (+ 3.72%) | M > F (< 0.001)p |
| HR(bpm)peak | NS | – (2.47%;< 0.01)p | NS (− 0.63%) | NS | ||
| VE/O\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2 | NS | – (5.62%;< 0.05)p | NS (− 3.96%) | NS | ||
| VE/VCO2 | NS | – (6.25%;< 0.05)p | NS (− 4.73%) | NS | ||
| Developed EIH post-HIIT | NER | = 7n | = 2n | NER | ||
| Did not develop EIH post-HIIT | NER | = 5n | = 8n | NER | ||
| Marterer 2020 [] [67] | Cycle ergo test, indirect calorimetry Arm cycle test, indirect calorimetry | Oxygen pulse—legs (mL/beat) | NER | + (11.36%;< 0.001)p | + (8.94%;= 0.001)p | M > F (= 0.008)p |
| HR—legspeak | NER | NS (= 0.251)p | NS (= 0.234)p | NS (= 0.982)p | ||
| Oxygen pulse—arms (mL/beat) | NER | + (7.39%;= 0.041)p | + (9.09%;= 0.004)p | NS (= 0.432)p | ||
| HR—armspeak | NER | NS (= 0.833)p | – (= 0.013)p | NS (= 0.096)p | ||
| RER—legs and armsmax | NER | NS | NS | NS | ||
| Correlational analysis,O—legs andO—arms\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2max2max | N/A | NS correlation to blood volume or Hb mass | NS correlation to blood volume or Hb mass | NS | ||
| Menz 2015 [] [87] | Carbon monoxide rebreathing method and capillary blood samples | Total hemoglobin mass (g and g/kg) | NER | NER | NER | NS, data pooled |
| Blood volume (ml/kg) | NER | NER | NER | NS, data pooled | ||
| Plasma volume (ml/kg) | NER | NER | NER | NS, data pooled | ||
| Maximal heart rate (bpm) | NER | NER | NER | NS, data pooled | ||
| Maximal oxygen pulse (ml/beat) | NER | NER | NER | NS, data pooled | ||
| RERmax | NER | NER | NER | NS, data pooled | ||
| Weber 2002 [] [74] | Timed cycling test to fatigue at 120%O, indirect calorimetry\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙2peak=MAODdifference between AOdemand and AOuptake22 | MAOD (L), Δ pre-mid training | M > F (< 0.01)p | + (14.3 ± 5.2%;< 0.05)p | + (14.0 ± 3.0%;< 0.01)p | NS |
| MAOD (L), Δ mid-post training | M > F (< 0.01)p | + (6.6 ± 1.9%;< 0.01)p | + (5.1 ± 2.3%;< 0.05)p | NS | ||
| AOdeficit (L)2 | M > F (< 0.01)p | – (< 0.01)p | NS | M > F (= NER)p | ||
| AOuptake (L)2 | M > F (< 0.05)p | + (< 0.01)p | NS | M > F (= NER)p | ||
| HR(bpm)peak | NS | – (< 0.05)p | – (< 0.05)p | NER | ||
Risk of Bias Within Studies
Quality appraisal scores for individual studies ranged from five to eight out of a maximum possible score of nine. The majority of studies (n = 17) were classified as good quality, indicating a low risk of bias for the current review. Eight trials were classified as fair and three trials were classified as poor. The mean inter-rater reliability for individual items of the NOS was 82.54% (± 12.17%; range 64.28–100%). The lowest inter-rater reliability scores were for the selection of men compared to women item and the withdrawals and non-adherers item. All included studies applied an equivalent intervention for males and females as indicated by question 7 on the NOS, demonstrating that prescribed exercise protocols were dose-matched between men and women within each meta-analysis. A detailed breakdown of scoring for each study can be seen in Supplementary Online Resource 5 in the ESM.
Correlation Coefficients
Seven studies [66–72] contributed data to the imputed correlation coefficients for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max, which were calculated as 0.79 (± 0.16) for women and 0.81 (± 0.10) for men. Four studies [67, 71, 73, 74] contributed data for peak power output from incremental exercise testing (PPO), which were calculated as 0.84 (± 0.07) for women and 0.81 (± 0.08) for men. Two studies [73, 75] contributed data for threshold power (power output at lactate or ventilatory threshold; powerAT), which were calculated as 0.53 (± 0.22) for women and 0.47 (± 0.16) for men.
Cardiorespiratory Fitness Outcomes
Maximal Oxygen Uptake: Study Characteristics and Primary Analysis
Three studies [82, 89, 90] were categorized as poor using the NOS and AHRQ criteria, and only two had sufficient data for meta-analysis [82, 90]. Upon removing these studies, sensitivity analysis revealed small changes in effect sizes for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in both men (g = 0.57; p < 0.001) and women (g = 0.52; p < 0.001). Similarly, only small changes in heterogeneity occurred for both men (I2 = 79.91%, Q = 79.64, p < 0.001) and women (I2 = 54.59%, Q = 35.23, p = 0.004). The impact of removing the data from these studies was considered to be small, and hence the data were retained for subsequent meta-analyses and sub-group analyses.
Initial qualitative analysis of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max outcomes revealed conflicting results regarding whether there were sex-specific differences when \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max was considered in relative or absolute terms. When absolute and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max outcomes were retrospectively meta-analyzed separately, effect sizes were found to be similar for men and women for both outcomes, without the presence of between-group differences for either measure (Table 3; Supplementary Online Resource 7, see ESM).
The sensitivity analysis for the meta-analytical approach and for estimating raw pooled mean differences found that baseline \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max was significantly higher in men compared with women for both absolute \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (between-group Δ 1.06 L·min−1; p < 0.001) and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (between-group Δ 5.88 mL·kg−1·min−1; p < 0.001). Heterogeneity was significant for both baseline absolute and baseline relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (I2 = 70% and 60% respectively; p = 0.001 for both). Pre-post response to HIIT/SIT interventions measured using a raw mean difference was similar between men and women with no significant between-group differences for change in either absolute (men, Δ 0.32 L·min−1 vs women, Δ 0.20 L·min−1; p = 0.38) or relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (men, Δ 3.50 mL·kg−1·min−1 versus women, Δ 3.34 mL·kg−1·min−1; p = 0.88). Heterogeneity was low for the pre-post analysis of both absolute and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (I2 = 0% for both; p = 0.97 and p = 1.0, respectively). Forest plots for this sensitivity analysis are shown in Supplementary Online Resource 8a–d (see ESM).
![Click to view full size Meta-analysis ofO, pre- and post-HIIT or SIT intervention. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max HIIT SIT O LL UL](https://europepmc.org/articles/PMC10799129/bin/40279_2023_1914_Fig2_HTML.jpg.jpg)
Meta-analysis ofO, pre- and post-HIIT or SIT intervention. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max HIIT SIT O LL UL
Maximal Oxygen Uptake: Sub-Groupings
Sub-group analysis for men and women by the mean age of the participant group (Fig. 3b) did not account for significant levels of heterogeneity in any of the sub-groups, with the exception of women under 30 years (I2 = 35.93; p = 0.12). All significant heterogeneity in the men's 30–45-year-old group was accounted to one study [72]. The exclusion of this study resulted in a substantially lowered effect size for this group (g = 0.18) and a significant between-group difference overall (p < 0.001), indicating high sensitivity and a general lack of robustness within this particular analysis. Despite the application of the age categories, participants over 45 years actually only consisted of studies with a mean age of ≥ 59 years.
![Click to view full size Sub-grouping of meta-analysis ofO, pre- and post-HIIT or SIT intervention,by baseline training status, andby mean group age. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max a b HIIT SIT O LL UL](https://europepmc.org/articles/PMC10799129/bin/40279_2023_1914_Fig3_HTML.jpg.jpg)
Sub-grouping of meta-analysis ofO, pre- and post-HIIT or SIT intervention,by baseline training status, andby mean group age. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max a b HIIT SIT O LL UL
![Click to view full size Sub-grouping of meta-analysis ofO, pre- and post-HIIT or SIT intervention,by intervention type, andby intervention length. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max a b HIIT SIT O LL UL](https://europepmc.org/articles/PMC10799129/bin/40279_2023_1914_Fig4_HTML.jpg.jpg)
Sub-grouping of meta-analysis ofO, pre- and post-HIIT or SIT intervention,by intervention type, andby intervention length. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,maximal oxygen uptake,confidence interval lower limit,confidence interval upper limit \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ 2max 2max a b HIIT SIT O LL UL
Performance Outcomes

Meta-analysis of peak power out from incremental exercise testing (PPO), pre- and post-HIIT or SIT intervention. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,confidence interval lower limit,confidence interval upper limit HIIT SIT LL UL

Sub-grouping of meta-analysis of peak power out from incremental exercise testing (PPO), pre- and post-HIIT or SIT intervention,by baseline training status, andby intervention type. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,confidence interval lower limit,confidence interval upper limit a b HIIT SIT LL UL

Meta-analysis of threshold power (Power), pre- and post-HIIT or SIT intervention. Standardized mean differences and 95% confidence intervals.high-intensity interval training,sprint interval training,confidence interval lower limit,confidence interval upper limit AT HIIT SIT LL UL
Peak Power Output from Incremental Testing
Eight trials reporting peak power output from incremental testing were meta-analyzed [67, 74, 83–85, 92, 93, 96]. All trials tested PPO using a cycle ergometer protocol. Results demonstrated significant increases in PPO for all female and male subgroups. Women consistently demonstrated larger percent increases (6.71–13.99%) and effect sizes (g, range 0.35–0.77) for PPO compared to men (2.56–12.23%; g, range: 0.17–0.60), and the between-group difference reached the threshold for statistical significance in the sub-grouping by baseline training status, due to the larger effect size for well-trained women (g = 0.37) compared with well-trained men (g = 0.17; p = 0.05). Baseline training status accounted for all significant heterogeneity in PPO in moderately trained and well-trained men and women (I2, range: 0.00–54.31%; p, range: 0.14–0.93); however, significant levels of heterogeneity were present for the total sample and untrained sub-groups (I2, range: 54.58–79.57%; p, range: 0.00–0.09). Due to the smaller number of studies, PPO could not be sub-grouped by mean group age or intervention length.
Meta-Analysis of Threshold Power
Five trials [67, 73, 75, 84, 85] presented sufficient data to meta-analyze outcomes relating to powerAT. No differences were demonstrated between men and women (p = 0.96). The percent increase in powerAT for men was 7.09 ± 7.17% (small effect size: g = 0.38; p < 0.01), and that for women was 8.07 ± 6.55% (small effect size: g = 0.38; p < 0.01). Some inconsistency existed in the units presented for these outcomes (e.g., work presented as Watts, W/kg, and speed in m/s) and the measures of anaerobic thresholds (lactate thresholds and ventilatory thresholds both included); however, despite this, heterogeneity was not significant, and the grouping of these outcomes appeared to be appropriate. Results demonstrated small increases in powerAT for men and women with low heterogeneity (men: I2 = 29.85%, Q = 5.70, p = 0.22; women: I2 = 31.26%, Q = 5.82, p = 0.21). Due to the small number of studies presenting relevant data, outcomes for powerAT could not be further sub-grouped.
Additional Performance Outcomes
A summary of results for additional performance outcomes and measures of fatigue is shown in Table 7. Most performance outcomes showed no significant differences in the magnitude of improvement between men and women. In cases where significant sex × HIIT interactions existed, these included a greater improvement in mean and maximal Wingate power output [97], repeated sprint speed decrement [95], and a 3000-m cycling time trial [98] for women compared to men. Additionally, one study demonstrated a significant correlation between the change in power output at the second lactate threshold (LT2) and the change in 40-km time trial performance for women (r2 = 0.77; p < 0.01) [73], while no relationships with any of the measured variables were present for men (r2 = 0.01–0.21; p all < 0.05). One study demonstrated a greater improvement in men for the mean power of the third of four repeated sprints within SIT sessions (pertaining to less power decrement over repeated sprints) [91].
Concurrent Measures of Physiological Adaptation
Various physiological adaptions that were measured alongside other fitness and performance outcomes were reported in 15 trials [67, 70, 74, 76, 78–80, 83, 85–87, 91, 93, 96, 97]. These included maximal accumulated oxygen deficit (MAOD; n = 1) [74], various blood lactate measures (n = 8) [67, 70, 73, 74, 79, 85, 86, 95, 96], cardiac adaptations (n = 1) [80], mitochondrial and metabolic adaptations (n = 3) [81, 91, 93, 97], muscle fiber types (n = 1) [97], and correlational analyses for fitness or performance outcomes (n = 4) [67, 73, 80, 96]. A summary of the results relating to these concurrent measures of physiological adaptation is shown in Table 8.
Sex × HIIT interactions for most blood lactate and cellular or muscular measures were either not reported or not significant. Cases where significant interactions indicated greater increases in women compared to men after HIIT included maximal [67] or post-test blood lactate [70], type II muscle fiber cross-sectional area [97], and muscle glycogen content [97]. Conversely, significant interactions where men demonstrated greater increases compared to women included total muscle creatine content [97], muscle fiber β-HAD activity and GLUT4 protein content [83], coupled and uncoupled mitochondrial respiratory capacity [81], muscle mitochondrial biogenesis [91], and muscle protein synthesis [91]. All significant sex × HIIT interactions relating to central cardiorespiratory measures other than \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max indicated greater changes for men compared to women following HIIT. These included significant interactions for increases in maximum carbon dioxide output [76], peak cardiac output [80], peak stroke volume [80], peak cardiac index [80], maximal minute ventilation [70], oxygen pulse [67], and accumulated oxygen uptake [74], and decreases in accumulated oxygen deficit [74].
Assessment of Publication Bias
A visual inspection of the symmetry of the datapoint distribution for powerAT shows no asymmetry as an indication of notable publication bias in the pre-post effect meta-analysis. Observed and adjusted effect sizes were equivalent at 0.37 (95% CI 0.22–0.53); however, it should be noted that this meta-analysis only included data from five studies. Additionally, some reporting bias for all meta-analyzed outcomes was noted with some studies reporting a lack of sex differences in outcomes and thereby pooling male and female data. Although efforts were taken to obtain data from authors where possible, this type of reporting has resulted in some missing data from the meta-analyses. It is, however, unlikely that this missing data would have significantly affected the results for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and powerAT, since these strongly indicated no between-group differences in the magnitude of adaptation. The meta-analysis of PPO could have benefitted from additional data which may have influenced the final results.
![Click to view full size Funnel plots of the pre-post effect size (standardized mean differences; Hedges’) versus standard error formaximal oxygen uptake (O),peak power output from incremental exercise testing (PPO), andthreshold power (Power) in response to HIIT or SIT interventions. Funnels represent the 95% prediction interval for pooled, observed effect size.high-intensity interval training,sprint interval training g HIIT SIT a b c \documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\dot{V}$$\end{document} V ˙ 2max AT](https://europepmc.org/articles/PMC10799129/bin/40279_2023_1914_Fig8_HTML.jpg.jpg)
Funnel plots of the pre-post effect size (standardized mean differences; Hedges’) versus standard error formaximal oxygen uptake (O),peak power output from incremental exercise testing (PPO), andthreshold power (Power) in response to HIIT or SIT interventions. Funnels represent the 95% prediction interval for pooled, observed effect size.high-intensity interval training,sprint interval training g HIIT SIT a b c \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document} V ˙ 2max AT
Discussion
The main finding of the current review with meta-analyses is that men and women improve fitness and performance outcomes to a similar extent following equivalent HIIT and SIT interventions. In particular, meta-analyzed outcomes for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and powerAT revealed strikingly similar small to moderate increases for men and women. These findings are consistent with those of Weston and colleagues [50], who found moderate improvements in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in active and sedentary adults in response to HIIT. Until recently, there has been insufficient research to conclude whether or not sex differences exist in fitness adaptations to HIIT interventions. Our findings expand on the work of Weston and colleagues [50], who could not come to a conclusion regarding a sex-specific response to HIIT, by demonstrating near-identical effect sizes in women and men and a lack of significant between-group differences for the primary meta-analysis of any outcome.
The sensitivity analysis that was undertaken to estimate raw mean differences found that baseline \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in men was significantly higher, the equivalent of 1.06 L·min−1 or 5.88 mL·kg−1·min−1, compared with women, as expected. The pre-post analysis using a raw mean difference indicated significant overall improvements of approximately 0.23 L·min−1 and 3.40 mL·kg−1·min−1, without the presence of significant between-group differences for men and women. This analysis indicates that the general results were not altered by the use of a standardized mean difference designed for dependent data and provides more practical estimates of effect. The results of this analysis should be taken with some caution, however, since the meta-analytical approach assumes independent data. In particular, the low levels of heterogeneity in the pre-post analyses appear to be underestimated.
While larger effect sizes for PPO were demonstrated for women compared with men across all sub-groupings, this difference only reached the threshold of significance in participants who were well trained at baseline. Despite the presence of this apparent difference, it must be noted that the well-trained male and female sub-groups only consisted of two studies and had a small sample size of only 18 men and 19 women. Baseline training status accounted for all significant heterogeneity in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and PPO outcomes in moderately trained and well-trained men and women. While decreases in the variability of outcomes for participants who were trained at baseline could make sense from a physiological standpoint as fitness and performance outcomes move closer to a theoretical physiological ceiling, it is unclear from the current analysis what factors contributed to the variability of outcomes for untrained participants.
A significant between-group difference was present overall for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max when sub-grouped by baseline training status, with smaller effect sizes present for the moderately trained groups. This likely reflected some confounding from shorter intervention lengths in the moderately trained groups. All except one study within the moderately trained groups had an intervention length ranging between 2 and 4 weeks, while studies in the well-trained category had a range of 6–8 weeks. Consistent with this, the sub-grouping by intervention length revealed significant between-group differences with smaller effect sizes seen for interventions of ≤ 4 weeks in duration for both sexes. While the female data demonstrated a gradual increase in effect size with longer interventions, the male data demonstrated similar effect sizes but greater variability with all sub-groups longer than 4 weeks in duration. Interestingly, these findings are consistent with the study by Hirsch et al. [72], who highlighted potential differences in the rate of adaptation between men and women, with significant changes in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max occurring during the first 4 weeks for the men in their study, while the significant changes in women occurred during the second 4 weeks.
Conversely, the sub-group analyses for mean group age and intervention type (HIIT versus SIT) did not significantly influence the heterogeneity in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max or PPO outcomes and revealed no significant between-group differences. Furthermore, the observed sensitivity of the mean age sub-group analysis indicated fundamental issues with the robustness of this grouping, and as such these results should be interpreted with caution. Overall, it appears that baseline training status and intervention length may be important factors influencing the variability of outcomes in response to HIIT and SIT interventions for both sexes, rather than age or intervention type.
Except for conflicting evidence regarding fatigue and speed/power decrement, the qualitative analysis of results of the additional performance outcomes (outlined in Table 7) demonstrated a similar lack of differences between men and women regarding the magnitude of change for most performance outcomes. Generally, the included studies supported current knowledge that women are less fatigable than men [66, 73, 76, 91, 95, 96] prior to HIIT. While some of the studies included in this review indicated that men may be able to adapt this to a greater extent than women through HIIT [91, 93], some studies found significant improvements in fatigability or power output through repeated efforts in women only [95, 97], while still other studies found no sex differences at all regarding the change in fatigability [66, 73, 76, 96].
Despite the notable lack of sex differences in the magnitude of adaptation of fitness and performance outcomes in response to HIIT, some of the findings outlined in Tables 7 and 8 indicated potential differences regarding the underlying mechanisms contributing to these improvements. Most notably, all significant sex × HIIT interactions reported in the primary studies that related to central cardiorespiratory adaptations favored men, with women generally demonstrating smaller, and often non-significant changes. Examples of this included the observed increases in peak cardiac output, peak stroke volume, and peak cardiac index in men only after SIT, as demonstrated by Bostad et al. [80]; the significant sex × HIIT interaction for oxygen pulse (the amount of oxygen ejected from the ventricles with each cardiac contraction) with a greater increase in men compared with women as demonstrated by Marterer and colleagues [67]; the increases in accumulated oxygen uptake and decreases in accumulated oxygen deficit after HIIT seen only in men, as demonstrated by Weber and Schneider [74]; and finally, the increases in minute ventilation and decreases in maximum heart rate and the ventilatory equivalents for oxygen and carbon dioxide in men only, as demonstrated by Mucci and colleagues [70]. These findings, together with the increase in coupled and uncoupled mitochondrial respiratory capacity that was demonstrated in men only, as outlined by Chrøis et al. [81], indicate that improvements in oxygen delivery and uptake in men may play a greater role in achieving fitness and performance adaptations after HIIT compared with women. While adaptations to high-intensity exercise via improvements in oxygen delivery and uptake may seem counter-intuitive on initial contemplation, previous studies have indicated that the greater oxygen availability during exercise in women provides an advantage with regard to the fatigability of muscular contractions, even at maximal intensities [43, 99]. Consistent with this, it appears that the sex differences in fatigability can be eliminated under ischemic conditions [100]. As such, it is conceivable that such adaptations may contribute to improvements in maximal fitness and performance outcomes. Similar findings have also been reported in a previous review of responses to endurance training, where increases in left ventricular end-diastolic volume and stroke volume increased to a greater extent in men compared with women [101]. Although this meta-analysis reported outcomes using mean differences, thereby reporting absolute changes in these outcomes, the results reported in the primary studies included in the current review indicate that these differences may also exist in these changes when considered relative to baseline.
In contrast, there was a relative lack of evidence surrounding the mechanisms of adaptation that account for the equivalent improvements in fitness and performance outcomes in women. Interestingly, the study by Hoffmann and colleagues [73] reported a significant correlation where a change in threshold power (LT2) accounted for 77% of the performance improvement in the 40 km cycling time trial for women. This same result was not observed for men, nor were there any significant correlations between change in time trial performance and measures of heart rate or blood lactate at LT2, absolute or relative peak power output, or incremental time to fatigue. Another study in the current review [97] found a significant increase in mean power during repeated Wingate tests and greater increases in the cross-sectional area of type IIb muscle fibers in women only in response to four weeks of SIT. Although these are the findings of only two studies, which could have been influenced by exercise mode since both used cycle-based testing and training protocols, some additional information can be gathered from outcomes that have been presented in other contexts. Spina and colleagues [102] compared mechanisms of adaptation in older men and women who participated in 9–12 months of moderate to vigorous uphill walking and running-based endurance training and found that 66% of the \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max adaption in older men was accounted for by a 15% increase in stroke volume in combination with a 7% increase in arteriovenous oxygen difference at maximal exercise. In contrast, this study found no change in stroke volume in older women and the whole change in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max could only be contributed to an increase in peripheral oxygen extraction. In another example, similar to the relationship noted by Hoffmann and colleagues [73], one cross-sectional study [103] found that 60% of the variability in 10-km performance for highly trained female runners aged 23–47 years was explained by running velocity at the lactate threshold. The authors noted, however, that this relationship was age-dependent, with \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max explaining 74% of the variability in performance in women aged 37–56 years. The potential differences highlighted here alongside the strikingly similar effect sizes seen for \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in the current meta-analysis suggest some potential sex differences in the adaptive responses to HIIT/SIT that may warrant further investigation.
Despite highlighting potential differences in the adaptative responses to HIIT and SIT in men and women, these appear to be only different means to the same end. Improvements in maximal cardiorespiratory fitness along with many other performance measures outlined in the results of the current review were found to occur to a similar magnitude in men and women. In contrast to this, a previous meta-analysis by Diaz-Canestro and Montero [52] reported greater increases in absolute and relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in men compared with women in response to moderate-intensity endurance training. This discrepancy between the results of these two meta-analyses may be influenced by the differing interventions (endurance training vs HIIT/SIT) or the methodological differences between the two meta-analyses. The earlier review by Diaz-Canestro and Montero [52] presented absolute change in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max (mL·kg−1·min−1 and mL·min−1) using raw mean differences, whereas the current review primarily focused on changes relative to baseline reflected as standardized effect sizes, percentage change, and sex × HIIT interactions (see also the comment by Senefeld and colleagues [104]). Despite these differences in overall approach, the sensitivity analysis using a raw mean difference in the current review persisted to indicate that there were no significant differences between men and women for either absolute or relative \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max in response to HIIT/SIT interventions. Overall, these findings seem to indicate that sex differences in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max response may be protocol dependent, and could warrant further investigation.
Limitations
The current review has a number of limitations. Firstly, in order to minimize confounding from different exercise protocols (exercise dose) across studies, only studies that presented both male and female data were included in the current review. While this ensures that exercise dose is normalized between male and female sub-groups and provides relatively similar numbers of men and women within each analysis, the majority of the included studies were small, which limits the number of participants within the meta-analyses overall. Since studies with small sample sizes tend to be associated with larger effect sizes and greater error, some of the effect sizes seen here have the potential to be overestimated or unduly influenced by a small number of participants. Despite this, the focus of the current review was to identify differences between the relative change in outcomes for men and women rather than quantifying effect sizes. The general effects of HIIT, particularly with relation to \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max, have been demonstrated for mixed male and female groups in previous meta-analyses [4, 9, 50], and the current analysis strongly indicates that sex differences in the relative change in these outcomes are minimal.
Another potential limitation of the current meta-analysis could be that while prescribed training doses were matched between men and women in all studies, there was an inability to properly assess the actual dose received in many studies and whether this was consistent with the prescribed dose (dose delivered). Many studies provided only basic details regarding compliance to prescribed exercise, with only a few reporting that this remained consistent between men and women. Despite this, many of the included studies appeared to have been tightly controlled interventions, in which case the differences between the prescribed and actual training doses are unlikely to have been substantially different.
In addition to the small pooled sample size and challenges associated with assessing the fidelity of the interventions, the use of pre-post meta-analysis techniques and multiple effect sizes from individual studies in the same analysis (such as the matched male and female sub-group data) have been widely used, but also widely debated in the literature [105–107]. While the use of dependent pre-post data has been largely accounted for with the use of correlation coefficients in the meta-analyses, sufficient data was not available to calculate correlation coefficients for all studies, therefore many of these were imputed. Furthermore, while the design of the current review ensures that prescribed exercise dose is matched between male and female groups, the wide range of intervention lengths and exercise protocols included in the literature makes it difficult to precisely examine the influence of different protocols on these outcomes. Overall, the approaches used within the current review with meta-analyses aimed to minimize statistical and methodological errors as much as possible in the face of the unique set of challenges associated with the research question; however, the results should be considered within the constraints of the limitations that are outlined here.
Finally, while the current review provides some insight into generalized similarities and differences between men and women regarding physiological adaptations to HIIT interventions, evaluation of the influence of hormonal status on outcomes was outside of the scope of this review. While the influence of hormonal fluctuations in women may be somewhat offset by the current focus on adaptation over several sessions, generally spanning weeks or months, these concepts appeared to be largely overlooked in the included studies and should be a focus of future primary and secondary research. Despite the limitations outlined here, the findings from the current review will be critical in order to fill the research gaps and to promote better optimization of exercise prescription and health for both women and men.
Conclusions
The current review with meta-analyses aimed to clarify sex differences in the adaptations of fitness and performance outcomes in response to HIIT and SIT interventions. The main findings of this review indicated that the magnitude of change in \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and powerAT in response to HIIT interventions is similar for men and women. While a borderline significant sex difference was found for PPO in well-trained men and women, the sub-groups consisted of small sample sizes and therefore should be interpreted with caution. Additionally, qualitative analysis of performance outcomes and concurrent measures of physiological adaptation indicated potential differences in the underlying mechanisms of adaptation for men and women. Lastly, it appears that baseline training status and intervention length may play a role in influencing the variability of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\dot{V}$$\end{document}V˙O2max and PPO outcomes in both sexes, including significantly smaller effect sizes for interventions with a duration of 4 weeks or less.
Supplementary Information
Below is the link to the electronic supplementary material. Supplementary file1 (XLSX 158 KB) Supplementary file2 (PDF 1577 KB)